[1] Dos Santos Picanco LC, Ozela PF, de Fatima de Brito Brito M, Pinheiro AA, Padilha EC, Braga FS, de Paula da Silva CHT, Dos Santos CBR, Rosa JMC, da Silva Hage-Melim LI. Alzheimer's disease:a review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment[J]. Curr Med Chem, 2018, 25:3141-3159. [2] Jensen-Dahm C, Waldemar G, Staehelin Jensen T, Malmqvist L, Moeller MM, Andersen BB, Høgh P, Ballegaard M. Autonomic dysfunction in patients with mild to moderate Alzheimer's disease[J]. J Alzheimers Dis, 2015, 47:681-689. [3] GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet Neurol, 2019, 18:88-106. [4] Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, Iqbal K, Jessen F, Johansson G, Jönsson L, Kivipelto M, Knapp M, Mangialasche F, Melis R, Nordberg A, Rikkert MO, Qiu C, Sakmar TP, Scheltens P, Schneider LS, Sperling R, Tjernberg LO, Waldemar G, Wimo A, Zetterberg H. Defeating Alzheimer's disease and other dementias:a priority for European science and society[J]. Lancet Neurol, 2016, 15:455-532. [5] Zakrzewska-Pniewska B, Gawel M, Szmidt-Salkowska E, Kepczynska K, Nojszewska M. Clinical and functional assessment of dysautonomia and its correlation in Alzheimer's disease[J]. Am J Alzheimers Dis Other Demen, 2012, 27:592-599. [6] Xiong L, Leung TWH. Autonomic dysfunction in neurological disorders[J]. Aging (Albany NY), 2019, 11:1903-1904. [7] Aziz NA, Anguelova GV, Marinus J, van Dijk JG, Roos RA. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease[J]. Eur J Neurol, 2010, 17:1068-1074. [8] Stubendorff K, Aarsland D, Minthon L, Londos E. The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia[J]. PLoS One, 2012, 7:e45451. [9] Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA. Autonomic dysfunction in dementia[J]. J Neurol Neurosurg Psychiatry, 2007, 78:671-677. [10] Idiaquez J, Roman GC. Autonomic dysfunction in neurodegenerative dementias[J]. J Neurol Sci, 2011, 305:22-27. [11] Allan LM. Diagnosis and management of autonomic dysfunction in dementia syndromes[J]. Curr Treat Options Neurol, 2019, 21:38. [12] Xu JY, Liu S, Shi ZH, Hu WZ, Gan JH, Zhao YJ, Ji Y. A comparative analysis of clinical manifestations of Alzheimer's disease patients and Lewy body dementia patients[J]. Zhonghua Lao Nian Yi Xue Za Zhi, 2018, 37:636-640.[徐俊英, 刘帅, 石志鸿, 胡文政, 甘景环, 赵玉瑾, 纪勇. 阿尔茨海默病与路易体痴呆患者临床表现对比分析[J]. 中华老年医学杂志, 2018, 37:636-640.] [13] Cersosimo MG, Benarroch EE. Central control of autonomic function and involvement in neurodegenerative disorders[J]. Handb Clin Neurol, 2013, 117:45-57. [14] Thaisetthawatkul P, Boeve BF, Benarroch EE, Sandroni P, Ferman TJ, Petersen R, Low PA. Autonomic dysfunction in dementia with Lewy bodies[J]. Neurology, 2004, 62:1804-1809. [15] Viramo P, Luukinen H, Koski K, Laippala P, Sulkava R, Kivelä SL. Orthostatic hypotension and cognitive decline in older people[J]. J Am Geriatr Soc, 1999, 47:600-604. [16] Bendini C, Angelini A, Salsi F, Finelli ME, Martini E, Neviani F, Mussi C, Neri M. Relation of neurocardiovascular instability to cognitive, emotional and functional domains[J]. Gerontol Geriatr, 2007, 44 Suppl 1:69-74. [17] Yap PL, Niti M, Yap KB, Ng TP. Orthostatic hypotension, hypotension and cognitive status:early comorbid markers of primary dementia[J]? Dement Geriatr Cogn Disord, 2008, 26:239-246. [18] Struhal W, Javor A, Brunner C, Benesch T, Schmidt V, Vosko MR, Ransmayr G. The phoenix from the ashes:cardiovascular autonomic dysfunction in behavioral variant of frontotemporal dementia[J]. J Alzheimers Dis, 2014, 42:1041-1046. [19] Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Research criteria for the diagnosis of Alzheimer's disease:revising the NINCDS-ADRDA criteria[J]. Lancet Neurol, 2007, 6:734-746. [20] Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Severe impairment battery language scale:a language-assessment tool for Alzheimer's disease patients[J]. Alzheimers Dement, 2009, 5:375-379. [21] Wang ZY, Zhang MY. Chinese version of simple intelligent state check (MMSE) application[J]. Shanghai Jing Shen Yi Xue, 1989, 7:108-111.[王征宇, 张明园. 中文版简易智能状态检查(MMSE)的应用[J]. 上海精神医学, 1989, 7:108-111.] [22] Wang G. Handbook of rating scales for neuropsychological assessment of dementia and associated cognitive disorders[M]. 2nd ed. Beijing:Science Press, 2021:60-61.[王刚. 痴呆及认知障碍神经心理测评量表手册[M]. 2版. 北京:科学出版社, 2021:60-61.] [23] De Pablo-Fernandez E, Tur C, Revesz T, Lees AJ, Holton JL, Warner TT. Association of autonomic dysfunction with disease progression and survival in Parkinson disease[J]. Neurol, 2017, 74:970-976. [24] Hu WZ, Gan JH, Liu S, Zhao YJ, Li ZL, Shi ZH, Ji Y. Symptom characteristics of autonomic dysfunction in AD and DLB[J]. A Er Ci Hai Mo Bing Ji Xiang Guan Bing, 2019, 2:245-249.[胡文政, 甘景环, 刘帅, 赵玉瑾, 李张龙, 石志鸿, 纪勇. 阿尔茨海默病与路易体痴呆自主神经功能障碍的症状特点[J]. 阿尔茨海默病及相关病, 2019, 2:245-249.] [25] Femminella GD, Rengo G, Komici K, Iacotucci P, Petraglia L, Pagano G, de Lucia C, Canonico V, Bonaduce D, Leosco D, Ferrara N. Autonomic dysfunction in Alzheimer's disease:tools for assessment and review of the literature[J]. J Alzheimers Dis, 2014, 42:369-377. [26] Issac TG, Chandra SR, Gupta N, Rukmani MR, Deepika S, Sathyaprabha TN. Autonomic dysfunction:a comparative study of patients with Alzheimer's and frontotemporal dementia:a pilot study[J]. J Neurosci Rural Pract, 2017, 8:84-88. [27] Du XS, Liu S, Hu WZ, Gan JH, Zhu H, Shi ZH, Ji Y. Characteristics of autonomic dysfunction in Alzheimer's disease[J]. A Er Ci Hai Mo Bing Ji Xiang Guan Bing, 2019, 2:510-516.[杜晓姗, 刘帅, 胡文政, 甘景环, 朱涵, 石志鸿, 纪勇. 阿尔茨海默病患者自主神经功能障碍特点分析[J]. 阿尔茨海默病及相关病, 2019, 2:510-516.] [28] Na HR, Park MH, Cho ST, Lee BC, Park S, Kim KH, Choi JB. Urinary incontinence in Alzheimer's disease is associated with clinical dementia rating-sum of boxes and barthel activities of daily living[J]. Asia Pac Psychiatry, 2015, 7:113-120. [29] Chiang CH, Wu MP, Ho CH, Weng SF, Huang CC, Hsieh WT, Hsu YW, Chen PJ. Lower urinary tract symptoms are associated with increased risk of dementia among the elderly:a nationwide study[J]. Biomed Res Int, 2015:ID187819. [30] Ransmayr GN, Holliger S, Schletterer K, Heidler H, Deibl M, Poewe W, Madersbacher H, Kiss G. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease[J]. Neurology, 2008, 70:299-303. [31] Andersson M, Hansson O, Minthon L, Ballard CG, Londos E. The period of hypotension following orthostatic challenge is prolonged in dementia with Lewy bodies[J]. Int J Geriatr Psychiatry, 2008, 23:192-198. [32] Sonnesyn H, Nilsen DW, Rongve A, Nore S, Ballard C, Tysnes OB, Aarsland D. High prevalence of orthostatic hypotension in mild dementia[J]. Dement Geriatr Cogn Disord, 2009, 28:307-313. [33] Mehrabian S, Duron E, Labouree F, Rollot F, Bune A, Traykov L, Hanon O. Relationship between orthostatic hypotension and cognitive impairment in the elderly[J]. J Neurol Sci, 2010, 299:45-48. [34] Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, Ozawa T. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community[J]. Stroke, 1997, 28:2169-2173. [35] Ballard C, O'Brien J, Barber B, Scheltens P, Shaw F, McKeith I, Kenny RA. Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia[J]. Ann NY Acad Sci, 2000, 903:442-445. [36] Chen SW, Wang YK, Dou RH, Xie XY, Hu YB, Ding N, Zhang GH, Jing HF, Zhao WD, Xue Y, Li Y, Wang G. Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease:the SFC BP multicentre study in China[J]. J Hypertens, 2020, 38:2270-2278. [37] Xiong Z. Agmatine improves hypothermia response in a streptozotocin-induced Alzheimer rat[D]. Chengdu:Chengdu Yi Xue Yuan, 2016.[熊资. 胍丁胺对链脲菌素致阿尔茨海默病大鼠低温反应的改善作用[D]. 成都:成都医学院, 2016.] [38] Ren RJ, Yin P, Wang ZH, Qi JL, Tang R, Wang JT, Huang Q, Li JP, Xie XY, Hu YB, Cui SS, Yu XP, Zhu Y, Liu XY, Zhu YK, Lin SH, Wang YR, Huang YY, Hu YS, Wang XF, Wang HL, Chu JS, Wang Y, Li CB, Zhou MG, Wang G, China Alzheimer's Disease Report Writing Group. Chinese Alzheimer's disease report 2021[J]. Zhen Duan Xue Li Lun Yu Shi Jian, 2021, 20:317-337.[任汝静, 殷鹏, 王志会, 齐金蕾, 汤然, 王金涛, 黄强, 李建平, 谢心怡,胡勇博, 崔诗爽, 余小萍, 朱圆, 刘馨雅, 朱怡康, 林绍慧, 王怡然,黄延焱, 胡以松, 王学锋, 王鸿利, 褚敬申, 王颖, 李春波, 周脉耕, 王刚, 中国阿尔茨海默病报告编写组. 中国阿尔茨海默病报告2021[J]. 诊断学理论与实践, 2021, 20:317-337.] |